We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Clear Channel Outdoor Holdings
CCO
$1.23B
| $126K | ﹤0.01% |
46,544
-47,685
| -51% | -$119K |
|
1877
Hyliion Holdings
HYLN
$663M
| $126K | ﹤0.01% |
15,023
-15,394
| -51% | -$142K |
|
1878
SiriusPoint
SPNT
$2.98B
| $126K | ﹤0.01% |
13,606
-11,428
| -46% | -$110K |
|
1879
OraSure Technologies
OSUR
$273M
| $125K | ﹤0.01% |
11,026
-9,491
| -46% | -$104K |
|
|
DHC
1880
Diversified Healthcare Trust
DHC
$2.26B
| $124K | ﹤0.01% |
36,569
-31,485
| -46% | -$119K |
|
1881
Spyre Therapeutics
SYRE
$8.87B
| $124K | ﹤0.01% |
626
-146
| -19% | -$25.5K |
|
|
PSTX
1882
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $124K | ﹤0.01% |
17,002
-1,628
| -9% | -$14K |
|
|
AVDL
1883
DELISTED
Avadel Pharmaceuticals
AVDL
| $122K | ﹤0.01% |
12,477
+1,983
| +19% | +$15.6K |
|
1884
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $122K | ﹤0.01% |
10,710
-2,664
| -20% | -$34.7K |
|
|
VXRT
1885
DELISTED
Vaxart
VXRT
| $122K | ﹤0.01% |
15,309
-15,681
| -51% | -$129K |
|
|
RTL
1886
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $122K | ﹤0.01% |
15,144
-13,246
| -47% | -$112K |
|
1887
Comstock Resources
CRK
$3.97B
| $121K | ﹤0.01% |
11,738
-12,022
| -51% | -$81.4K |
|
1888
Summit Therapeutics
SMMT
$10.9B
| $121K | ﹤0.01% |
24,181
+877
| +4% | +$6.29K |
|
|
AKUS
1889
DELISTED
Akouos Inc
AKUS
| $121K | ﹤0.01% |
10,442
-1,975
| -16% | -$23.7K |
|
1890
DHT Holdings
DHT
$2.97B
| $119K | ﹤0.01% |
18,167
-19,399
| -52% | -$112K |
|
1891
Dianthus Therapeutics
DNTH
$5.68B
| $119K | ﹤0.01% |
1,022
-117
| -10% | -$13.6K |
|
|
BDSI
1892
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $119K | ﹤0.01% |
32,996
-8,873
| -21% | -$33.5K |
|
1893
Workhorse Group
WKHS
$29.5M
| $118K | ﹤0.01% |
5
-6
| -55% | -$182K |
|
|
PAYA
1894
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $115K | ﹤0.01% |
10,534
-10,796
| -51% | -$116K |
|
1895
AC Immune
ACIU
$227M
| $114K | ﹤0.01% |
17,036
+3,983
| +31% | +$28.5K |
|
1896
Perdoceo Education
PRDO
$1.9B
| $114K | ﹤0.01% |
10,826
-9,345
| -46% | -$105K |
|
1897
ProPetro Holding
PUMP
$1.45B
| $114K | ﹤0.01% |
13,126
-11,248
| -46% | -$87.9K |
|
1898
WisdomTree
WT
$2.97B
| $114K | ﹤0.01% |
20,066
-19,003
| -49% | -$117K |
|
1899
CytomX Therapeutics
CTMX
$705M
| $113K | ﹤0.01% |
22,232
-6,276
| -22% | -$33.6K |
|
|
JNCE
1900
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $113K | ﹤0.01% |
15,170
-2,584
| -15% | -$16K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.